Beaziz, J.; Battistella, M.; Delyon, J.; Farges, C.; Marco, O.; Pages, C.; Le Maignan, C.; Da Meda, L.; Basset-Seguin, N.; Resche-Rigon, M.;
et al. Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans. Cancers 2021, 13, 2224.
https://doi.org/10.3390/cancers13092224
AMA Style
Beaziz J, Battistella M, Delyon J, Farges C, Marco O, Pages C, Le Maignan C, Da Meda L, Basset-Seguin N, Resche-Rigon M,
et al. Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans. Cancers. 2021; 13(9):2224.
https://doi.org/10.3390/cancers13092224
Chicago/Turabian Style
Beaziz, Jessica, Maxime Battistella, Julie Delyon, Cécile Farges, Oren Marco, Cécile Pages, Christine Le Maignan, Laetitia Da Meda, Nicole Basset-Seguin, Matthieu Resche-Rigon,
and et al. 2021. "Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans" Cancers 13, no. 9: 2224.
https://doi.org/10.3390/cancers13092224
APA Style
Beaziz, J., Battistella, M., Delyon, J., Farges, C., Marco, O., Pages, C., Le Maignan, C., Da Meda, L., Basset-Seguin, N., Resche-Rigon, M., Walter Petrich, A., Kérob, D., Lebbé, C., & Baroudjian, B.
(2021). Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans. Cancers, 13(9), 2224.
https://doi.org/10.3390/cancers13092224
